LYNN STOCKWELL ENTERS INTO A RESTRUCTURING SECURITY AGREEMENT (“RSA”) WITH BRIGHT GREEN CORPORATION AND ASSUMES THE ROLE OF EXECUTIVE CHAIR AND CEO.

Core Viewpoint - Bright Green Corporation is undergoing a restructuring to align its operations with the vision of its founder, Lynn Stockwell, focusing on on-shoring active pharmaceutical ingredient (API) manufacturing to the United States [3][10]. Restructuring Details - Lynn Stockwell has agreed to a restructuring security agreement (RSA) with Bright Green, which will involve the cancellation of all existing contracts, land purchase options, employment agreements, and financing agreements [3][4][11]. - The company plans to complete a shareholder-approved reverse split and seek re-listing on a major exchange, with Stockwell remaining the majority shareholder and part of the new management team [4][11]. Revenue Generation Strategy - Bright Green aims to derive revenue from production and supply contracts for plant-based controlled substances, leveraging its existing registrations and licenses [5][7]. - The company is exploring a franchise-based business model to build agricultural facilities across West Texas, East Arizona, and Central New Mexico, with each facility featuring 15-acre specialty greenhouses [6][7]. EB-5 Program Integration - The initiative integrates the USCIS EB-5 program, allowing qualifying franchisees to earn U.S. Green Cards through investments that create jobs, which aligns with the company's goals [6][7]. - Bright Green will manage facility development, including loan guarantees and supply contracts for agricultural production and pharmaceutical-grade controlled substances [7]. Market Positioning - The restructured company is positioned to supply plant-based controlled substances to U.S. drug manufacturers, which is critical for maintaining competitiveness in the evolving manufacturing landscape [10].